Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline Prophylaxis vs Incentive Payments for Syphilis Prevention in HIV+ MSM
NCT02257658Completed
- Sponsor
- Los Angeles LGBT Center
- Start
- Sep 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of doxycycline in syphilis (2 arms), sponsored by Los Angeles LGBT Center. Primary endpoint: Incidence of Syphilis, Gonorrhea and Chlamydia at 48 weeks. Started Sep 2011; status: completed.
02
Drugs
doxycycline
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT02257658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257658.